oncology clinical trial

LUND, Sweden, June 22, 2026 Hamlet BioPharma AB has announced a significant expansion of its U.S. clinical development program...

CHICAGO, Illinois and SAN CARLOS, California — May 27, 2026 BeOne Medicines announced new clinical findings from the Phase...

LUND, Sweden, May 27, 2026 Hansa Biopharma AB has announced positive topline results from its European Post Authorization Efficacy...

BOSTON, May 27, 2026 TransCode Therapeutics, Inc., a clinical-stage biotechnology company focused on RNA-based cancer therapeutics, has announced the...

LONDON, United Kingdom, May 26, 2026 Virax Biolabs Group Limited has announced encouraging early clinical data for ViraxImmune™, its...

CRANFORD, New Jersey, May 26, 2026 Citius Oncology, Inc. has announced that new Phase 1 clinical study data evaluating...

SAN ANTONIO, Texas, May 19, 2026 Valion Bio, Inc. has announced a high-level joint engagement with senior officials from...

CARY, N.C. and BRADENTON, Fla., May 20, 2026 Continuity Biosciences has announced the initiation of a Phase I first-in-human...

BOSTON – May 8, 2026 Day One Biopharmaceuticals, now part of Servier Group, announced the completion of patient enrollment...

SOUTH SAN FRANCISCO, Calif., May 7, 2026 ALX Oncology announced promising new clinical findings showing that its investigational CD47...